Clinical Trial Update: Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve [Phase 4]

View source ↗

Summary

Phase 4 trial assessing microvascular dysfunction in nonischemic cardiomyopathy using CMR-derived coronary flow reserve; the study was terminated with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy
• Microvascular Ischaemia of Myocardium
• Non-ischemic Dilated Cardiomyopathy

Snippet

Sponsor: Duke University | Conditions: Hypertrophic Cardiomyopathy, Non-ischemic Dilated Cardiomyopathy | Phase 4 | Status: TERMINATED | Results posted: 2020-09-16